{"id":55137,"date":"2023-12-20T09:07:50","date_gmt":"2023-12-20T09:07:50","guid":{"rendered":"https:\/\/medsname.com\/forxiga-dapagliflozin\/"},"modified":"2026-05-01T10:49:12","modified_gmt":"2026-05-01T10:49:12","slug":"forxiga-dapagliflozin","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/forxiga-dapagliflozin\/","title":{"rendered":"Forxiga (Dapagliflozin)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 Rychl\u00e1 odpov\u011b\u010f \u2014 Co je Forxiga?<\/h3>\n<p style=\"margin:0;\"><strong>Forxiga<\/strong> je zna\u010dka <strong>dapagliflozin<\/strong> (5 mg nebo 10 mg), <strong>inhibitor SGLT-2<\/strong> (\u201cgliflozin\u201d) pou\u017e\u00edvan\u00fd p\u0159i <strong>cukrovce 2. typu, srde\u010dn\u00edm selh\u00e1n\u00ed a chronick\u00e9m onemocn\u011bn\u00ed ledvin (CKD)<\/strong>. P\u016fsob\u00ed blokov\u00e1n\u00edm zp\u011btn\u00e9ho vst\u0159eb\u00e1v\u00e1n\u00ed gluk\u00f3zy v ledvin\u00e1ch, co\u017e vede k vylu\u010dov\u00e1n\u00ed 70\u201390 g gluk\u00f3zy denn\u011b mo\u010d\u00ed. T\u00edm sni\u017euje hladinu gluk\u00f3zy v krvi nez\u00e1visle na inzul\u00ednu, zp\u016fsobuje \u00fabytek hmotnosti o 2\u20133 kg, pokles krevn\u00edho tlaku o 3\u20135 mmHg a \u2014 jedine\u010dn\u011b mezi antidiabetiky \u2014 sni\u017euje hospitalizace pro srde\u010dn\u00ed selh\u00e1n\u00ed a zpomaluje progresi CKD u pacient\u016f s diabetem i bez n\u011bj. Sn\u00ed\u017een\u00ed HbA1c: 0,5\u20130,8 procentn\u00edch bod\u016f. D\u00e1vkov\u00e1n\u00ed: 10 mg jednou denn\u011b r\u00e1no, s j\u00eddlem nebo bez. Pro n\u011bkter\u00e9 pacienty je k dispozici s\u00edla 5 mg. Pro indikace srde\u010dn\u00edho selh\u00e1n\u00ed nebo CKD: 10 mg\/den. <strong>Nezp\u016fsobuje hypoglyk\u00e9mii<\/strong> jako monoterapie. Hlavn\u00ed rizika: genit\u00e1ln\u00ed kandid\u00f3za (\u010dast\u00e1, m\u00edrn\u00e1), infekce mo\u010dov\u00fdch cest, vz\u00e1cn\u011b diabetick\u00e1 ketoacid\u00f3za (n\u011bkdy s t\u00e9m\u011b\u0159 norm\u00e1ln\u00ed hladinou gluk\u00f3zy \u2013 \u201ceuglykemick\u00e1 DKA\u201d) a sn\u00ed\u017een\u00ed objemu tekutin. Nevhodn\u00e9 pro diabetes 1. typu.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">Co je Forxiga?<\/h2>\n<p>Forxiga je peror\u00e1ln\u00ed inhibitor SGLT-2 (sodno-gluk\u00f3zov\u00e9ho kotransport\u00e9ru-2) obsahuj\u00edc\u00ed <strong>dapagliflozin<\/strong> (5 mg nebo 10 mg), vyr\u00e1b\u011bno spole\u010dnost\u00ed AstraZeneca. Dostupn\u00e9 v balen\u00edch po 28, 56 nebo 84 tablet\u00e1ch. Je schv\u00e1leno pro:<\/p>\n<ul>\n<li>Diabetes 2. typu \u2013 pro kontrolu glyk\u00e9mie, obvykle jako dopln\u011bk k metforminu nebo jako druh\u00e1 volba<\/li>\n<li>Srde\u010dn\u00ed selh\u00e1n\u00ed \u2013 jak se sn\u00ed\u017eenou (HFrEF), tak zachovanou (HFpEF) ejek\u010dn\u00ed frakc\u00ed, bez ohledu na diabetes<\/li>\n<li>Chronick\u00e9 onemocn\u011bn\u00ed ledvin \u2013 ke zpomalen\u00ed progrese, s diabetem i bez n\u011bj<\/li>\n<\/ul>\n<p>dapagliflozin byl poprv\u00e9 schv\u00e1len v roce 2012 (origin\u00e1ln\u00ed zna\u010dka: Forxiga v EU \/ Farxiga v USA, AstraZeneca). Je to jedna z klinicky nejv\u00fdznamn\u011bj\u0161\u00edch t\u0159\u00edd antidiabetik v posledn\u00edm desetilet\u00ed, proto\u017ee stejn\u00fd l\u00e9k sou\u010dasn\u011b l\u00e9\u010d\u00ed t\u0159i nej\u010dast\u011bj\u0161\u00ed dlouhodob\u00e9 komplikace diabetu.<\/p>\n<h2 class=\"wp-block-heading\">Jak Forxiga funguje?<\/h2>\n<p>Zdrav\u00e9 ledviny denn\u011b profiltruj\u00ed 180 g gluk\u00f3zy p\u0159es glomeruly a t\u00e9m\u011b\u0159 v\u0161echnu ji zp\u011btn\u011b vst\u0159ebaj\u00ed do krevn\u00edho \u0159e\u010di\u0161t\u011b prost\u0159ednictv\u00edm transport\u00e9ru SGLT-2 v proxim\u00e1ln\u00edm tubulu. U diabetu je tato reabsorpce ve skute\u010dnosti <em>zes\u00edlena<\/em> \u2013 t\u011blo zadr\u017euje v\u00edce gluk\u00f3zy pr\u00e1v\u011b tehdy, kdy\u017e by ji m\u011blo \u010d\u00e1st uvolnit.<\/p>\n<p>dapagliflozin selektivn\u011b blokuje SGLT-2, co\u017e zp\u016fsobuje vylu\u010dov\u00e1n\u00ed 70\u201390 g gluk\u00f3zy denn\u011b mo\u010d\u00ed. To:<\/p>\n<ul>\n<li><strong>Sni\u017euje hladinu gluk\u00f3zy v krvi p\u0159ibli\u017en\u011b o 30\u201350 mg\/dL<\/strong> \u2014 nez\u00e1visle na inzulinu<\/li>\n<li><strong>Sni\u017euje hmotnost o 2\u20133 kg<\/strong> \u2014 ztr\u00e1ta gluk\u00f3zy mo\u010d\u00ed odpov\u00edd\u00e1 p\u0159ibli\u017en\u011b 280\u2013320 kcal\/den<\/li>\n<li><strong>Sni\u017euje systolick\u00fd krevn\u00ed tlak o 3\u20135 mmHg<\/strong> \u2014 \u010d\u00e1ste\u010dn\u011b osmotickou diur\u00e9zou, \u010d\u00e1ste\u010dn\u011b jin\u00fdmi mechanismy<\/li>\n<li><strong>Sni\u017euje intraglomerul\u00e1rn\u00ed tlak<\/strong> \u2014 zpomaluje progresi chronick\u00e9ho onemocn\u011bn\u00ed ledvin<\/li>\n<li><strong>Zlep\u0161uje energetick\u00fd metabolismus srdce<\/strong> \u2014 p\u0159isp\u00edv\u00e1 k benefit\u016fm u srde\u010dn\u00edho selh\u00e1n\u00ed<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kardiovaskul\u00e1rn\u00ed, srde\u010dn\u00ed a ren\u00e1ln\u00ed benefity<\/h2>\n<p>dapagliflozin m\u00e1 neobvykle silnou datab\u00e1zi v\u00fdsledk\u016f klinick\u00fdch studi\u00ed:<\/p>\n<ul>\n<li><strong>DECLARE-TIMI 58 (2019)<\/strong> \u2014 sn\u00ed\u017eil kombinovan\u00fd ukazatel kardiovaskul\u00e1rn\u00ed mortality nebo hospitalizace pro srde\u010dn\u00ed selh\u00e1n\u00ed; MACE byl nehor\u0161\u00ed.<\/li>\n<li><strong>DAPA-HF (2019)<\/strong> \u2014 26% sn\u00ed\u017een\u00ed zhor\u0161en\u00ed srde\u010dn\u00edho selh\u00e1n\u00ed nebo kardiovaskul\u00e1rn\u00ed mortality u pacient\u016f s HFrEF, bez ohledu na stav diabetu. <strong>DELIVER (2022)<\/strong> roz\u0161\u00ed\u0159il prosp\u011bch na HFpEF.<\/li>\n<li><strong>DAPA-CKD (2020)<\/strong> \u2014 39% sn\u00ed\u017een\u00ed progrese CKD, studie byla p\u0159ed\u010dasn\u011b ukon\u010dena pro \u00fa\u010dinnost. Prosp\u011bch u CKD s nebo bez diabetu 2. typu.<\/li>\n<\/ul>\n<p>Tyto studie zm\u011bnily praxi: inhibitory SGLT-2 jsou nyn\u00ed doporu\u010dov\u00e1ny pro v\u0161echny pacienty s diabetem 2. typu, kte\u0159\u00ed maj\u00ed prok\u00e1zan\u00e9 kardiovaskul\u00e1rn\u00ed onemocn\u011bn\u00ed, srde\u010dn\u00ed selh\u00e1n\u00ed nebo chronick\u00e9 onemocn\u011bn\u00ed ledvin \u2014 bez ohledu na hodnotu HbA1c.<\/p>\n<h2 class=\"wp-block-heading\">D\u00e1vkov\u00e1n\u00ed a pod\u00e1n\u00ed<\/h2>\n<p><strong>Standardn\u00ed d\u00e1vka:<\/strong> 10 mg jednou denn\u011b r\u00e1no, s j\u00eddlem nebo bez. K dispozici je tak\u00e9 s\u00edla 5 mg pro n\u011bkter\u00e9 pacienty. Pro indikace srde\u010dn\u00edho selh\u00e1n\u00ed nebo CKD: 10 mg\/den.<\/p>\n<ul>\n<li>Jednodenn\u00ed d\u00e1vkov\u00e1n\u00ed; \u010das pod\u00e1n\u00ed lze p\u0159izp\u016fsobit denn\u00edmu re\u017eimu.<\/li>\n<li>Nen\u00ed nutn\u00e9 u\u017e\u00edvat s j\u00eddlem (s v\u00fdjimkou canagliflozinu).<\/li>\n<li>Vynechan\u00e1 d\u00e1vka \u2014 u\u017eijte, pokud si vzpomenete do 12 hodin; jinak vynechejte.<\/li>\n<li><strong>Forxiga\/dapagliflozin:<\/strong> Zah\u00e1jen\u00ed l\u00e9\u010dby je povoleno p\u0159i eGFR \u226525 ml\/min\/1,73 m\u00b2 u indikac\u00ed srde\u010dn\u00ed selh\u00e1n\u00ed\/chronick\u00e9 onemocn\u011bn\u00ed ledvin; pokra\u010dujte a\u017e do dial\u00fdzy. U diabetick\u00e9 glykemick\u00e9 kontroly \u00fa\u010dinnost kles\u00e1 pod eGFR 45.<\/li>\n<li>Nezahajovat l\u00e9\u010dbu b\u011bhem akutn\u00edho onemocn\u011bn\u00ed s dehydratac\u00ed (riziko akutn\u00edho po\u0161kozen\u00ed ledvin a euglykemick\u00e9 ketoacid\u00f3zy).<\/li>\n<li><strong>Pravidla pro nemocn\u00e9 dny:<\/strong> p\u0159i jak\u00e9mkoli akutn\u00edm onemocn\u011bn\u00ed s zvracen\u00edm, pr\u016fjmem nebo sn\u00ed\u017een\u00fdm p\u0159\u00edjmem potravy p\u0159eru\u0161te u\u017e\u00edv\u00e1n\u00ed SGLT-2 inhibitoru. Obnovte p\u0159i norm\u00e1ln\u00ed strav\u011b.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Vedlej\u0161\u00ed \u00fa\u010dinky<\/h2>\n<p><strong>\u010cast\u00e9:<\/strong><\/p>\n<ul>\n<li><strong>Mykotick\u00e9 infekce genit\u00e1li\u00ed (kandid\u00f3za)<\/strong> \u2014 a\u017e u 10 % u\u017eivatel\u016f, v\u011bt\u0161inou \u017een. Snadno l\u00e9\u010diteln\u00e9 antimykotiky.<\/li>\n<li><strong>Infekce mo\u010dov\u00fdch cest<\/strong> \u2014 m\u00edrn\u011b \u010dast\u011bj\u0161\u00ed; v\u011bt\u0161inou jde o prostou cystitidu.<\/li>\n<li>Zv\u00fd\u0161en\u00e9 mo\u010den\u00ed (polyurie), m\u00edrn\u00e1 dehydratace, z\u00e1vrat\u011b p\u0159i postaven\u00ed (ortostatick\u00e1 hypotenze) \u2014 zejm\u00e9na v prvn\u00edch 2 t\u00fddnech.<\/li>\n<li>M\u00edrn\u00e9 zv\u00fd\u0161en\u00ed LDL-cholesterolu (obvykle &lt; 0,2 mmol\/l).<\/li>\n<\/ul>\n<p><strong>M\u00e9n\u011b \u010dast\u00e9, ale d\u016fle\u017eit\u00e9:<\/strong><\/p>\n<ul>\n<li><strong>Diabetick\u00e1 ketoacid\u00f3za (DKA)<\/strong> \u2014 vz\u00e1cn\u00e1 (&lt; 0,1 % ro\u010dn\u011b), ale m\u016f\u017ee se vyskytnout i p\u0159i t\u00e9m\u011b\u0159 norm\u00e1ln\u00ed hladin\u011b gluk\u00f3zy (\u201ceuglykemick\u00e1 DKA\u201d). Rizikov\u00e9 faktory: sn\u00ed\u017een\u00fd p\u0159\u00edjem sacharid\u016f, akutn\u00ed onemocn\u011bn\u00ed, chirurgick\u00fd z\u00e1krok, sn\u00ed\u017een\u00ed d\u00e1vky inzul\u00ednu. P\u0159\u00edznaky: nevolnost, zvracen\u00ed, bolesti b\u0159icha, zrychlen\u00e9 d\u00fdch\u00e1n\u00ed. <strong>P\u0159eru\u0161te u\u017e\u00edv\u00e1n\u00ed l\u00e9ku a vyhledejte neodkladnou p\u00e9\u010di.<\/strong><\/li>\n<li><strong>Objemov\u00e1 deplece<\/strong> \u2014 vy\u0161\u0161\u00ed riziko u star\u0161\u00edch dosp\u011bl\u00fdch, osob u\u017e\u00edvaj\u00edc\u00edch diuretika nebo s n\u00edzk\u00fdm v\u00fdchoz\u00edm krevn\u00edm tlakem.<\/li>\n<li><strong>Akutn\u00ed po\u0161kozen\u00ed ledvin<\/strong> \u2014 obvykle preren\u00e1ln\u00ed p\u0159i dehydrataci; reverzibiln\u00ed po vysazen\u00ed l\u00e9ku.<\/li>\n<li><strong>Fournierova gangr\u00e9na<\/strong> \u2014 extr\u00e9mn\u011b vz\u00e1cn\u00e9 nekrotizuj\u00edc\u00ed infekce perinea; l\u00e9ka\u0159sk\u00e1 pohotovost.<\/li>\n<li>Nebyl zaznamen\u00e1n sign\u00e1l zv\u00fd\u0161en\u00e9ho rizika amputac\u00ed.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interakce s l\u00e9\u010divy<\/h2>\n<ul>\n<li><strong>Diuretika (zejm\u00e9na kli\u010dkov\u00e1 a thiazidov\u00e1)<\/strong> \u2014 aditivn\u00ed ztr\u00e1ta tekutin; zva\u017ete sn\u00ed\u017een\u00ed d\u00e1vky diuretika p\u0159i zah\u00e1jen\u00ed l\u00e9\u010dby.<\/li>\n<li><strong>Inzul\u00edn a sulfonylmo\u010doviny<\/strong> \u2014 aditivn\u00ed hypoglykemizuj\u00edc\u00ed \u00fa\u010dinek; tyto d\u00e1vky m\u016f\u017ee b\u00fdt nutn\u00e9 sn\u00ed\u017eit, aby se p\u0159ede\u0161lo hypoglyk\u00e9mii.<\/li>\n<li><strong>Lithium<\/strong> \u2014 zv\u00fd\u0161en\u00e9 vylu\u010dov\u00e1n\u00ed mo\u010d\u00ed m\u016f\u017ee zv\u00fd\u0161it hladiny lithia.<\/li>\n<li><strong>Rifampicin<\/strong> \u2014 sni\u017euje hladiny inhibitor\u016f SGLT-2; m\u016f\u017ee b\u00fdt nutn\u00e1 vy\u0161\u0161\u00ed d\u00e1vka.<\/li>\n<li><strong>Antihypertenziva<\/strong> \u2014 aditivn\u00ed sn\u00ed\u017een\u00ed krevn\u00edho tlaku; sledujte z\u00e1vrat\u011b.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kdo by nem\u011bl u\u017e\u00edvat Forxigu?<\/h2>\n<ul>\n<li>Diabetes mellitus 1. typu (pokud nen\u00ed pod\u00e1v\u00e1n off-label a pod dohledem specialisty)<\/li>\n<li>Diabetick\u00e1 ketoacid\u00f3za \u2013 sou\u010dasn\u00e1 nebo ned\u00e1vn\u00e1 anamn\u00e9za<\/li>\n<li>T\u011b\u017ek\u00e9 ren\u00e1ln\u00ed posti\u017een\u00ed pod hranic\u00ed pro zah\u00e1jen\u00ed l\u00e9\u010dby<\/li>\n<li>Kone\u010dn\u00e9 stadium onemocn\u011bn\u00ed ledvin p\u0159i dial\u00fdze (empagliflozin se vysazuje po zah\u00e1jen\u00ed dial\u00fdzy; dapagliflozin m\u016f\u017ee b\u00fdt podle n\u011bkter\u00fdch protokol\u016f pokra\u010dov\u00e1n)<\/li>\n<li>T\u011b\u017ek\u00e1 dehydratace nebo hypotenze<\/li>\n<li>T\u011bhotenstv\u00ed a kojen\u00ed \u2014 omezen\u00e9 \u00fadaje; vyvarujte se<\/li>\n<li>Zn\u00e1m\u00e1 p\u0159ecitliv\u011blost na inhibitory SGLT-2<\/li>\n<li>Canagliflozin: p\u0159edchoz\u00ed amputace doln\u00ed kon\u010detiny nebo aktivn\u00ed v\u0159ed na noze (relativn\u00ed kontraindikace)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Skladov\u00e1n\u00ed<\/h2>\n<p>Skladujte Forxigu p\u0159i teplot\u00e1ch do 30 \u00b0C na such\u00e9m m\u00edst\u011b, v p\u016fvodn\u00edm blistru. Uchov\u00e1vejte mimo dosah d\u011bt\u00ed.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3 class=\"wp-block-heading\">Je Forxiga tot\u00e9\u017e co dapagliflozin?<\/h3>\n<p>Ano \u2014 Forxiga obsahuje dapagliflozin jako \u00fa\u010dinnou l\u00e1tku. Regula\u010dn\u00ed org\u00e1ny vy\u017eaduj\u00ed bioekvivalenci, tak\u017ee klinick\u00fd \u00fa\u010dinek je p\u0159i stejn\u00e9 d\u00e1vce stejn\u00fd.<\/p>\n<h3 class=\"wp-block-heading\">Je dapagliflozin tot\u00e9\u017e co Jardiance?<\/h3>\n<p>Ne \u2014 jedn\u00e1 se o dva r\u016fzn\u00e9 inhibitory SGLT-2 s podobn\u00fdmi t\u0159\u00eddn\u00edmi \u00fa\u010dinky. Dapagliflozin (Forxiga) m\u00e1 data z klinick\u00fdch studi\u00ed DAPA-HF a DAPA-CKD; empagliflozin (Jardiance) m\u00e1 data ze studi\u00ed EMPA-REG, EMPEROR a EMPA-KIDNEY. Oba jsou schv\u00e1leny pro diabetes 2. typu, srde\u010dn\u00ed selh\u00e1n\u00ed (v\u010detn\u011b HFpEF) a chronick\u00e9 onemocn\u011bn\u00ed ledvin. U v\u011bt\u0161iny pacient\u016f se volba \u0159\u00edd\u00ed dostupnost\u00ed, cenou a preferenc\u00ed p\u0159edepisuj\u00edc\u00edho l\u00e9ka\u0159e.<\/p>\n<h3 class=\"wp-block-heading\">Pom\u016f\u017ee mi Forxiga zhubnout?<\/h3>\n<p>Ano, m\u00edrn\u011b \u2014 obvykle \u00fabytek 2\u20133 kg za 6\u201312 m\u011bs\u00edc\u016f. \u00dabytek v\u00e1hy je zp\u016fsoben t\u00edm, \u017ee va\u0161e ledviny vylu\u010duj\u00ed 70\u201390 g gluk\u00f3zy (~280\u2013320 kcal) denn\u011b mo\u010d\u00ed. Jde o re\u00e1ln\u00fd, ale omezen\u00fd efekt \u2014 neo\u010dek\u00e1vejte dramatick\u00e9 \u00fa\u010dinky jako u agonist\u016f GLP-1 receptor\u016f, nap\u0159\u00edklad semaglutidu (Ozempic, Wegovy) nebo tirzepatidu (Mounjaro).<\/p>\n<h3 class=\"wp-block-heading\">Sn\u00ed\u017e\u00ed Forxiga m\u016fj krevn\u00ed tlak?<\/h3>\n<p>Ano \u2014 o\u010dek\u00e1vejte pokles systolick\u00e9ho tlaku asi o 3\u20135 mmHg. Pokud ji\u017e u\u017e\u00edv\u00e1te l\u00e9ky na krevn\u00ed tlak a jste bl\u00edzko c\u00edlov\u00fdch hodnot, mo\u017en\u00e1 budete pot\u0159ebovat sn\u00ed\u017een\u00ed d\u00e1vky p\u0159i zah\u00e1jen\u00ed u\u017e\u00edv\u00e1n\u00ed Forxigy, abyste p\u0159ede\u0161li z\u00e1vrat\u00edm.<\/p>\n<h3 class=\"wp-block-heading\">M\u016f\u017ee Forxiga zp\u016fsobit kvasinkovou infekci nebo infekce mo\u010dov\u00fdch cest?<\/h3>\n<p>Ano \u2014 genit\u00e1ln\u00ed kvasinkov\u00e1 infekce je nej\u010dast\u011bj\u0161\u00edm vedlej\u0161\u00edm \u00fa\u010dinkem (a\u017e u 10 % u\u017eivatel\u016f, p\u0159ev\u00e1\u017en\u011b \u017een). Obvykle je m\u00edrn\u00e1 a snadno se l\u00e9\u010d\u00ed lok\u00e1ln\u00edmi nebo peror\u00e1ln\u00edmi antimykotiky. Infekce mo\u010dov\u00fdch cest jsou m\u00edrn\u011b \u010dast\u011bj\u0161\u00ed, ale v\u011bt\u0161inou nekomplikovan\u00e9. D\u016fle\u017eit\u00e1 je hygiena; v\u011bt\u0161ina pacient\u016f nemus\u00ed l\u00e9k vysadit.<\/p>\n<h3 class=\"wp-block-heading\">Mohu u\u017e\u00edvat Forxigu, pokud m\u00e9 ledviny nefunguj\u00ed dob\u0159e?<\/h3>\n<p>Ano \u2014 a ve skute\u010dnosti SGLT-2 inhibitory <em>chr\u00e1n\u00ed<\/em> ledviny p\u0159i chronick\u00e9m onemocn\u011bn\u00ed ledvin (CKD). Po\u010d\u00e1te\u010dn\u00ed limity se li\u0161\u00ed podle molekuly (viz \u010d\u00e1st o d\u00e1vkov\u00e1n\u00ed p\u0159i ren\u00e1ln\u00ed insuficienci), ale po zah\u00e1jen\u00ed l\u00e9\u010dby se obvykle pokra\u010duje a\u017e do dial\u00fdzy, proto\u017ee ochrann\u00fd \u00fa\u010dinek na ledviny p\u0159etrv\u00e1v\u00e1, i kdy\u017e \u00fa\u010dinek na sn\u00ed\u017een\u00ed glyk\u00e9mie sl\u00e1bne.<\/p>\n<h3 class=\"wp-block-heading\">Co m\u00e1m d\u011blat p\u0159i nemoci nebo p\u0159ed operac\u00ed?<\/h3>\n<p>P\u0159i jak\u00e9mkoli akutn\u00edm onemocn\u011bn\u00ed spojen\u00e9m s dehydratac\u00ed, zvracen\u00edm nebo sn\u00ed\u017een\u00fdm p\u0159\u00edjmem tekutin a b\u011bhem v\u011bt\u0161\u00edch chirurgick\u00fdch v\u00fdkon\u016f nebo p\u016fstu p\u0159eru\u0161te u\u017e\u00edv\u00e1n\u00ed Forxigy. T\u00edm se sn\u00ed\u017e\u00ed riziko euglykemick\u00e9 DKA a akutn\u00edho po\u0161kozen\u00ed ledvin. Obnovte u\u017e\u00edv\u00e1n\u00ed po n\u00e1vratu k norm\u00e1ln\u00edmu p\u0159\u00edjmu potravy a tekutin.<\/p>\n<h3 class=\"wp-block-heading\">Kde lze koupit Forxigu online?<\/h3>\n<p>Forxiga (5 mg nebo 10 mg) si m\u016f\u017eete objednat na MedsBase v balen\u00edch po 28, 56 nebo 84 tablet\u00e1ch. Dod\u00e1v\u00e1me po cel\u00e9m sv\u011bt\u011b, s diskr\u00e9tn\u00edm balen\u00edm a origin\u00e1ln\u00edmi l\u00e9ky od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP.<\/p>\n<h2 class=\"wp-block-heading\">Souvisej\u00edc\u00ed l\u00e9ky na diabetes<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/jardiance-empagliflozin\/\">Jardiance \u2014 Empagliflozin 25 mg (Boehringer)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/forxiga-dapagliflozin\/\">Forxiga \u2014 Dapagliflozin 5\/10 mg (AstraZeneca)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/invokana-canagliflozin\/\">Invokana \u2014 Canagliflozin 100 mg (Janssen)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/glyxambi-empagliflozin\/\">Glyxambi \u2014 Empagliflozin + Linagliptin kombinace<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/januvia\/\">Januvia \u2014 Sitagliptin (DPP-4 alternativa)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/glycomet-sr\/\">Glycomet SR \u2014 Metformin s prodlou\u017een\u00fdm uvol\u0148ov\u00e1n\u00edm<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/diabetes-medication\/\"><strong>Prohl\u00e9dnout v\u0161echny l\u00e9ky na diabetes<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 L\u00e9ka\u0159sk\u00e9 upozorn\u011bn\u00ed.<\/strong> Tato str\u00e1nka slou\u017e\u00ed pouze pro informa\u010dn\u00ed \u00fa\u010dely a nenahrazuje l\u00e9ka\u0159skou p\u00e9\u010di kvalifikovan\u00e9ho zdravotnick\u00e9ho pracovn\u00edka. Inhibitory SGLT-2 nesou mal\u00e9, ale z\u00e1va\u017en\u00e9 riziko euglykemick\u00e9 diabetick\u00e9 ketoacid\u00f3zy a sn\u00ed\u017een\u00ed objemu tekutin \u2014 v\u017edy u\u017e\u00edvejte pod l\u00e9ka\u0159sk\u00fdm dohledem s dodr\u017eov\u00e1n\u00edm pravidel pro dny nemoci.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Souvisej\u00edc\u00ed alternativy<\/h3>\n<p>Dal\u0161\u00ed produkty v <strong>Chronick\u00e1 onemocn\u011bn\u00ed<\/strong> kter\u00e9 z\u00e1kazn\u00edci tak\u00e9 prohl\u00ed\u017eej\u00ed:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/instgra\/\">Instgra<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/allegra\/\">Allegra<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/okacet\/\">Okacet<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/lasix\/\">Lasix<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/hyros\/\">Hyros<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Reguluje hladinu cukru v krvi<br \/>\n\u2705 Sni\u017euje srde\u010dn\u00ed selh\u00e1n\u00ed<br \/>\n\u2705 Pom\u00e1h\u00e1 <a title=\"Rybelsus \u00fa\u010dinn\u00e9 \u0159e\u0161en\u00ed pro hubnut\u00ed\" href=\"https:\/\/medsbase.com\/cs\/rybelsus-an-effective-solution-for-weight-loss\/\">Hubnut\u00ed<\/a><br \/>\n\u2705 Zlep\u0161uje zdrav\u00ed ledvin<br \/>\n\u2705 <a title=\"Jak sn\u00ed\u017eit krevn\u00ed tlak\" href=\"https:\/\/medsbase.com\/cs\/how-to-lower-your-blood-pressure\/\">Sni\u017euje krevn\u00ed tlak<\/a><\/p>\n<p><span style=\"color: #999999;\">Forxiga obsahuje Dapagliflozin<\/span><\/p>","protected":false},"featured_media":55138,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[3868,3869],"class_list":{"0":"post-55137","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","10":"product_tag-dapagliflozin","11":"product_tag-forxiga","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/55137","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=55137"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/55138"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=55137"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=55137"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=55137"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=55137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}